Fairvalue-Calculator Fairvalue-Calculator
EN DE

GeneFerm Biotechnology Co (1796) Fair Value & Analysis

Healthcare · TW · Market cap 1.4B TWD

Price33.50 TWD
Fair Value15.32 TWD
Upside-54.3%
Quality95/100
Evidence: High Range 11.49 TWD – 19.14 TWD

Fair value as of: Jun 24, 2026

Analysis

GeneFerm Biotechnology Co (1796) currently trades at 33.50 TWD, while our model-based Fair Value estimate is 15.32 TWD — implying the stock looks roughly 54.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well as probiotics and peptide ingredients. It also provides private label supplements; and microbial fermentation toll manufacturing services. The company was founded in 1999 and is headquartered in Tainan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is GeneFerm Biotechnology Co (1796) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 15.32 TWD versus a price of 33.50 TWD — about −54% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1796?
Our 21-model fair value for GeneFerm Biotechnology Co is 15.32 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 33.50 TWD.
What is the quality score of 1796?
GeneFerm Biotechnology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.